"10.1371_journal.pone.0084895","plos one","2014-01-15T00:00:00Z","Rafael Fenutría; Vanesa G Martinez; Inês Simões; Jorge Postigo; Victor Gil; Mario Martínez-Florensa; Jordi Sintes; Rodrigo Naves; Kevin S Cashman; José Alberola-Ila; Manel Ramos-Casals; Gloria Soldevila; Chander Raman; Jesús Merino; Ramón Merino; Pablo Engel; Francisco Lozano","Institut dInvestigacions Biomédiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Departamento de Biología Molecular, Universidad de Cantabria, Santander, Spain; Servei de Malalties Autoimmunes Sistémiques, Hospital Clínic de Barcelona, Barcelona, Spain; Departament de Biologia Cel·lular, Immunologia i Neurociències, Universitat de Barcelona, Barcelona, Spain; Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States of America; Department of Microbiology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America; Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, United States of America; Departamento de Inmunología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Distrito Federal, México; Instituto de Biomedicina y Biotecnología de Cantabria, Consejo Superior de Investigaciones Científicas-Universidad de Cantabria-SODERCAN, Santander, Spain; Servei dImmunologia, Hospital Clínic de Barcelona, Barcelona, Spain","Conceived and designed the experiments: RF VGM JM RM MRC CR GS JAI PE FL. Performed the experiments: RF VGM IS JP VG MMF JS RN KSC JM RM. Analyzed the data: RF VGM IS JP MRC JM RM JAI CR GS PE FL. Contributed reagents/materials/analysis tools: JM RM CR PE. Wrote the paper: RF VGM MRC JM RM JAI CR GS PE FL.","The authors hereby declare that even though this work has been the base for an application for a European Patent (No. n°: 11382172.2 New compounds derived from scavenger-like lymphocyte receptors for use in immunotherapy), it does not alter their adherence to all the PLOS ONE policies on sharing data and materials.","2014","01","Rafael Fenutría","RF",17,TRUE,10,11,12,10,TRUE,TRUE,FALSE,0,NA,FALSE
